Literature DB >> 18624303

CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.

Makoto Ishii1, Cory M Hogaboam, Amrita Joshi, Toshihiro Ito, Daniel J Fong, Steven L Kunkel.   

Abstract

The present study addressed the modulatory role of CC chemokine receptor 4 (CCR4) in Toll-like receptor (TLR) 9-mediated innate immunity and explored the underlying molecular mechanisms. Our results demonstrated that CCR4-deficient mice were resistant to both septic peritonitis induced by cecal ligation and puncture (CLP) and CpG DNA/D-galactosamine-induced shock. In bone marrow-derived macrophages (BMMPhi) from CLP-treated CCR4-deficient mice, TLR9-mediated pathways of MAPK/AP-1, PI3K/Akt, and IkappaB kinase (IKK)/NF-kappaB were impaired compared to wild-type (WT) cells. While TLR9 expression was not altered, the intensity of internalized CpG DNA was increased in CCR4-deficient macrophages when compared to WT macrophages. Pharmacological inhibitor studies revealed that impaired activation of JNK, PI3K/Akt, and/or IKK/NF-kappaB could be responsible for decreased proinflammatory cytokine expression in CCR4-deficient macrophages. Interestingly, the CCR4-deficient BMMPhi exhibited an alternatively activated (M2) phenotype and the impaired TLR9-mediated signal transduction responses in CCR4-deficient cells were similar to the signaling responses observed in WT BMMPhi skewed to an alternatively activated phenotype. These results indicate that macrophages deficient in CCR4 impart a regulatory influence on TLR9-mediated innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624303      PMCID: PMC2925393          DOI: 10.1002/eji.200838360

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

1.  CCR4 is a key modulator of innate immune responses.

Authors:  Traci L Ness; Jillian L Ewing; Cory M Hogaboam; Steven L Kunkel
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 2.  New vistas on macrophage differentiation and activation.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

Review 3.  Antiviral signaling through pattern recognition receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  J Biochem       Date:  2006-12-26       Impact factor: 3.387

4.  In vivo regulation of neutrophil apoptosis by C5a during sepsis.

Authors:  Ren-Feng Guo; Lei Sun; Hongwei Gao; Kevin X Shi; Daniel Rittirsch; Vidya J Sarma; Firas S Zetoune; Peter A Ward
Journal:  J Leukoc Biol       Date:  2006-09-22       Impact factor: 4.962

5.  Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response.

Authors:  A Matsukawa; C M Hogaboam; N W Lukacs; P M Lincoln; H L Evanoff; S L Kunkel
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

6.  CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway.

Authors:  David P Sester; Kristian Brion; Angela Trieu; Helen S Goodridge; Tara L Roberts; Jasmyn Dunn; David A Hume; Katryn J Stacey; Matthew J Sweet
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

Review 7.  CCR4 as a novel molecular target for immunotherapy of cancer.

Authors:  Takashi Ishida; Ryuzo Ueda
Journal:  Cancer Sci       Date:  2006-09-05       Impact factor: 6.716

8.  Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309.

Authors:  M Inngjerdingen; B Damaj; A A Maghazachi
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

9.  Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs.

Authors:  Makoto Ishii; Yukio Suzuki; Kei Takeshita; Naoki Miyao; Hiroyasu Kudo; Rika Hiraoka; Kazumi Nishio; Nagato Sato; Katsuhiko Naoki; Takuya Aoki; Kazuhiro Yamaguchi
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

Review 10.  How do chemokine/chemokine receptor activations affect tumorigenesis?

Authors:  Ann Richmond; Guo Huang Fan; Punita Dhawan; Jinming Yang
Journal:  Novartis Found Symp       Date:  2004
View more
  13 in total

1.  Epigenetic regulation of the alternatively activated macrophage phenotype.

Authors:  Makoto Ishii; Haitao Wen; Callie A S Corsa; Tianju Liu; Ana L Coelho; Ronald M Allen; William F Carson; Karen A Cavassani; Xiangzhi Li; Nicholas W Lukacs; Cory M Hogaboam; Yali Dou; Steven L Kunkel
Journal:  Blood       Date:  2009-06-30       Impact factor: 22.113

2.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

3.  Enhancement of macrophage inflammatory responses by CCL2 is correlated with increased miR-9 expression and downregulation of the ERK1/2 phosphatase Dusp6.

Authors:  William F Carson; Sarah E Salter-Green; Melissa M Scola; Amrita Joshi; Katherine A Gallagher; Steven L Kunkel
Journal:  Cell Immunol       Date:  2017-02-22       Impact factor: 4.868

4.  CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis.

Authors:  Makoto Ishii; Koichiro Asano; Ho Namkoong; Sadatomo Tasaka; Kosuke Mizoguchi; Takahiro Asami; Hirofumi Kamata; Yoshifumi Kimizuka; Hiroshi Fujiwara; Yohei Funatsu; Shizuko Kagawa; Jun Miyata; Ken Ishii; Masataka Nakamura; Hiroyuki Hirai; Kinya Nagata; Steven L Kunkel; Naoki Hasegawa; Tomoko Betsuyaku
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

5.  CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.

Authors:  Rukiye-Nazan E Dogan; Nancy Long; Eileen Forde; Kristen Dennis; Adam P Kohm; Stephen D Miller; William J Karpus
Journal:  J Leukoc Biol       Date:  2010-10-12       Impact factor: 4.962

6.  CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells.

Authors:  Karola Poppensieker; David-Marian Otte; Britta Schürmann; Andreas Limmer; Philipp Dresing; Eva Drews; Beatrix Schumak; Luisa Klotz; Jennifer Raasch; Alexander Mildner; Ari Waisman; Stefanie Scheu; Percy Knolle; Irmgard Förster; Marco Prinz; Wolfgang Maier; Andreas Zimmer; Judith Alferink
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

7.  Bone marrow mononuclear cells up-regulate toll-like receptor expression and produce inflammatory mediators in response to cigarette smoke extract.

Authors:  Junmin Zhou; Erika A Eksioglu; Nicole R Fortenbery; Xianghong Chen; Huaquan Wang; Pearlie K Epling-Burnette; Julie Y Djeu; Sheng Wei
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

8.  Redox and Inflammatory Signaling, the Unfolded Protein Response, and the Pathogenesis of Pulmonary Hypertension.

Authors:  Adiya Katseff; Raed Alhawaj; Michael S Wolin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

9.  CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis.

Authors:  Raphael Molinaro; Cyntia Pecli; Rafael F Guilherme; José Carlos Alves-Filho; Fernando Q Cunha; Claudio Canetti; Steven L Kunkel; Marcelo T Bozza; Claudia F Benjamim
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

10.  Differential transcriptomic response in the spleen and head kidney following vaccination and infection of Asian seabass with Streptococcus iniae.

Authors:  Junhui Jiang; Masato Miyata; Candy Chan; Si Yan Ngoh; Woei Chang Liew; Jolly M Saju; Kah Sing Ng; Fong Sian Wong; Yeng Sheng Lee; Siow Foong Chang; László Orbán
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.